retatrutide expanded access program eli lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% FDA authorises Expanded Access Program

But if you stay off the drug, expect cravings to return with full force

0% placebo) Headache (reported in at least 10% with bremelanotide) Local injection reactions: pain, redness, swelling Dizziness or lightheadedness Temporary increases in blood pressure Mild-to-moderate fatigue or malaise Rare but serious events include pronounced hypertensive episodes, severe allergic reactions, syncope, and less well-documented cardiac events in people with underlying heart disease

Active Ingredient: Lecithin, Bromeliad & Riboflavin (Vitamin B2) Highlights: Unique Formulation: Unlike most other fat dissolvers on the market, Lemon Bottle is formulated with a unique blend of ingredients for enhanced fat cell response including Riboflavin, Lecithin and Bromeliad

Dehydration is a serious concern for anyone on blood thinners because it can affect how your kidneys filter medications out of your system

FG reports consultancies or paid advisory board memberships for Eli Lilly, Medtronic, Novo Nordisk, Roche Diabetes Care, and Sanofi

GLP-1 and pancreatitis are linked by a warning that appears on every prescribing label, but the relationship is more reassuring than the warning suggests: the safety signal is real, yet the absolute risk is low, and large randomized trials plus meta-analyses have not shown a major increase in pancreatitis on these medications